United Therapeutics Corporation (UTHR) ownership: Top institutional holder: BlackRock, Inc. ($3.20B). Insider activity: Net Seller (0 buys, 20 sells). 3 recent congressional STOCK Act disclosures. SEC EDGAR first-party data.
| Holder | Shares | Market Value | Reported |
|---|---|---|---|
| BlackRock, Inc. | 5399649.00 | $3.20B | 2026-03-31 |
| VANGUARD GROUP INC | 4176016.00 | $2.03B | 2025-12-31 |
| Avoro Capital Advisors LLC | 2630000.00 | $1.56B | 2026-03-31 |
| WELLINGTON MANAGEMENT GROUP LLP | 2264247.00 | $1.34B | 2026-03-31 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 2003742.00 | $1.19B | 2026-03-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 1957539.00 | $1.16B | 2026-03-31 |
| STATE STREET CORP | 1843963.00 | $1.09B | 2026-03-31 |
| RENAISSANCE TECHNOLOGIES LLC | 1787019.00 | $1.06B | 2026-03-31 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Sell | null | 2026-06-16 | |
| Sell | null | 2026-06-16 | |
| Sell | null | 2026-06-16 | |
| Sell | null | 2026-06-16 | |
| Sell | null | 2026-06-16 | |
| Sell | null | 2026-06-16 | |
| Sell | null | 2026-06-16 | |
| Sell | null | 2026-06-16 |
Back to UTHR overview · UTHR earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.